
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for 0656.HK and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for 0656.HK and 80,000+ other tickers.
See exactly how 0656.HK's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 0656.HK and 80,000+ other tickers.
Fosun International Limited operates as a global conglomerate, concentrating its diverse activities within the health, lifestyle, wealth management, and advanced manufacturing sectors. Its reach extends across Mainland China, Portugal, and various international territories. The company's comprehensive business model is primarily organized into five distinct segments: Health: This division is dedicated to the research, development, production, distribution, and commercialization of pharmaceuticals, biopharmaceuticals, and other health-related products, complemented by medical and health…
No recent news available.